A retrospective study identified prognostic factors for long survival — 20+ years — in patients with primary myelofibrosis.
Researchers find trends among physical and emotional challenges associated with being the primary family caregiver of a patient with multiple myeloma.
Oncologist Ashley Rosko, MD, has a unique perspective on patient age: Biological age is more important than chronological age. Dr Rosko is founder and director of the Cancer and Aging Resiliency (CARE) Clinic, a multidisciplinary clinic designed to address the needs of older adults with cancer. The clinic is located in The James Cancer Hospital…
A retrospective study using a cohort of the ALiCCS Study sought to determine hospitalization risks among survivors of leukemia during childhood 20 years after diagnosis.
FDA grants approval to tagraxofusp-erzs (Elzonris), a first treatment for blastic plasmacytoid dentritic cell neoplasm and the first therapy to target CD123.